Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study (Q33388853)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study |
scientific article |
Statements
1 reference
Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study (English)
1 reference
Martin Dreyling
1 reference
Anjali Advani
1 reference
Bertrand Coiffier
1 reference
Myron S Czuczman
1 reference
James Foran
1 reference
Eva Gine
1 reference
Christian Gisselbrecht
1 reference
Nicolas Ketterer
1 reference
Sunita Nasta
1 reference
Ama Rohatiner
1 reference
Ingo G H Schmidt-Wolf
1 reference
Martin Schuler
1 reference
Jorge Sierra
1 reference
Jane N Winter
1 reference
Joseph Boni
1 reference
Erik Vandendries
1 reference
Mark Shapiro
1 reference
1 reference
Identifiers
1 reference